Table 2.
Demographic data and electroencephalographic abnormalities.
| EEG | p-value | Generalized Slowing | p-value | Focal slowing | p-value | Epileptiform | p-value | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Normal | Abnormal | No | Yes | No | Yes | No | Yes | |||||
| Number of patients | 100 (48.5%) | 106 (51.5%) | – | 167 (81.1%) | 39 (18.9%) | – | 148 (71.8%) | 58 (28.2%) | – | 197 (95.6%) | 9 (4.4%) | – |
| Mean Age ± SD (years) | 61.5 ± 12 | 66.97 ± 12 | 0.002 c,* | 62.96 ± 11 | 70.13 ± 11 | 0.001 c,* | 64.36 ± 13 | 64.21 ± 13 | 0.938 c | 64.01 ± 13 | 71.11 ± 10 | 0.098 c |
| Male | 60 (29.1%) | 58 (28.2%) | 0.444 a | 92 (44.7%) | 26 (12.6%) | 0.188 a | 87 (42.2%) | 31 (15%) | 0.486 b | 117 (56.8%) | 1 (0.5%) | 0.005 b |
| Female | 40 (19.4%) | 48 (23.3%) | 75 (36.4%) | 13 (6.3%) | 61 (29.6%) | 27 (13.1%) | 80 (38.8%) | 8 (3.9%) | ||||
| Smoking | ||||||||||||
| Yes | 35 (17%) | 24 (11.7%) | 0.050 a | 50 (24.3%) | 9 (4.4%) | 0.393 a | 45 (21.8%) | 14 (6.8%) | 0.397 a | 58 (28.2%) | 1 (0.5%) | 0.451 b |
| No | 65 (31.6%) | 82 (39.8%) | 117 (56.8%) | 30 (14.6%) | 103 (50%) | 44 (21.4%) | 139 (67.5%) | 8 (3.9%) | ||||
| Comorbidities | ||||||||||||
| Hypertension | ||||||||||||
| Yes | 68 (33%) | 88 (42.7%) | 0.012 a,* | 123 (59.7%) | 33 (16%) | 0.15 a | 109 (52.9%) | 47 (22.8%) | 0.266 a | 148 (71.8%) | 8 (3.9%) | 0.691 b |
| No | 32 (15.5%) | 18 (8.7%) | 44 (21.4%) | 6 (2.9%) | 39 (18.9%) | 11 (5.3%) | 49 (23.8%) | 1 (0.5%) | ||||
| Diabetes mellitus | ||||||||||||
| Yes | 40 (19.4%) | 58 (28.2%) | 0.035 a,* | 74 (35.9%) | 24 (11.7%) | 0.052 a | 67 (32.5%) | 31 (15%) | 0.290 a | 95 (46.1%) | 3 (1.5%) | 0.382 b |
| No | 60 (29.1%) | 48 (23.3%) | 93 (45.1%) | 15 (7.3%) | 81 (39.3%) | 27 (13.1%) | 102 (49.5%) | 6 (2.9%) | ||||
| Dyslipidemia | ||||||||||||
| Yes | 42 (20.4%) | 36 (17.5%) | 0.235 a | 64 (31.1%) | 14 (16.8%) | 0.779 a | 59 (28.6%) | 19 (9.2%) | 0.344 a | 75 (36.4%) | 3 (1.5%) | 1.000 b |
| No | 58 (28.2%) | 70 (34%) | 103 (50%) | 25 (12.1%) | 89 (43.2%) | 39 (18.9%) | 122 (59.2%) | 6 (2.9%) | ||||
| Atrial fibrillation | ||||||||||||
| Yes | 7 (3.4%) | 16 (7.8%) | 0.065 a | 16 (7.8%) | 7 (3.4%) | 0.135 a | 15 (7.3%) | 8 (3.9%) | 0.453 a | 22 (10.7%) | 1 (0.5%) | 1.000 b |
| No | 93 (45.1%) | 90 (43.7%) | 151 (73.3%) | 32 (15.5%) | 133 (64.6%) | 50 (24.3%) | 175 (85%) | 8 (3.9%) | ||||
| Coronary artery disease | ||||||||||||
| Yes | 9 (4.4%) | 10 (4.9%) | 0.914 a | 18 (8.7%) | 1 (0.5%) | 0.134 b | 11 (5.3%) | 8 (3.9%) | 0.182 a | 18 (8.7%) | 1 (0.5%) | 0.589 b |
| No | 91 (44.2%) | 96 (46.6%) | 149 (72.3%) | 38 (18.4%) | 137 (66.5%) | 50 (24.3%) | 179 (86.9%) | 8 (3.9%) | ||||
a
Pearson’s chi-square test.
b
Fisher’s exact test.
c
Independent t-test.
d
Mann Whitney test.
*
Significant, p<0.05.